Page last updated: 2024-08-24

cephalosporin c and Bowel Diseases, Inflammatory

cephalosporin c has been researched along with Bowel Diseases, Inflammatory in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bishu, S; Chiu, GF; El-Zaatari, M; Grasberger, H; Kao, JY; Lin, KD; Owyang, SY; Waljee, AK; Wu, DC; Zhang, M1
Higuchi, K; Houchi, H; Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T1
Borgundvaag, B; Croitoru, K; Gnanasuntharam, P; Le, B; Leung, W; Malhi, G; McGeer, AJ; Nguyen, GC; Silverberg, MS; Steinhart, AH; Thanabalan, R; Weizman, AV; Willey, BM1
Balasubramanian, S; Giannadaki, E; Greenstein, AJ; Manousos, ON; Mouzas, IA; Sachar, DB1

Other Studies

4 other study(ies) available for cephalosporin c and Bowel Diseases, Inflammatory

ArticleYear
Effects of Anti-Helicobacter pylori Therapy on Incidence of Autoimmune Diseases, Including Inflammatory Bowel Diseases.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:10

    Topics: Adult; Aged; Anti-Bacterial Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Case-Control Studies; Cephalosporins; Colitis, Ulcerative; Crohn Disease; Dermatomyositis; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Inflammatory Bowel Diseases; Lupus Erythematosus, Systemic; Male; Middle Aged; Mortality; Pemphigus; Peptic Ulcer; Polymyositis; Proportional Hazards Models; Scleroderma, Systemic; Sjogren's Syndrome; Taiwan; Urinary Tract Infections; Vasculitis

2019
Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2008, Volume: 14, Issue:2

    Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Ascitic Fluid; Bacteria, Aerobic; Cefepime; Cephalosporins; Female; Humans; Inflammatory Bowel Diseases; Male; Microbial Sensitivity Tests; Monte Carlo Method; Peritonitis

2008
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:7

    Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Histamine H2 Antagonists; Hospitalization; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Middle Aged; Nose; Prevalence; Proton Pump Inhibitors; Rectum; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance; Young Adult

2012
Management of varicella infection during the course of inflammatory bowel disease.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:9

    Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Azathioprine; Cause of Death; Cephalexin; Cephalosporins; Chickenpox; Child; Colectomy; Colitis, Ulcerative; Crohn Disease; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intravenous; Male; Megacolon, Toxic; Methylprednisolone; Prednisone; Rectum; Remission Induction; Treatment Outcome

1997
chemdatabank.com